Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
about
Cannabinoids for epilepsyCannabinoids for epilepsyCannabinoids for epilepsyMultifunctional drugs for head injuryUse of magnesium in traumatic brain injuryAlcohol and marijuana: effects on epilepsy and use by patients with epilepsy.Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.The therapeutic potential of the cannabinoids in neuroprotection.Novel therapies in development for the treatment of traumatic brain injury.Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta.The therapeutic potential of cannabinoids for movement disorders.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.Pharmacology of traumatic brain injury: where is the "golden bullet"?Endocannabinoids: A Promising Impact for Traumatic Brain Injury.Acute management of acquired brain injury part II: an evidence-based review of pharmacological interventions.Cannabinoids, multiple sclerosis and neuroprotection.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Crystal structures of agonist-bound human cannabinoid receptor CB1.Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke.Recent advances in epilepsy.Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells.Slim evidence for cannabinoids for epilepsy.Neuropharmacology and therapeutic potential of cannabinoids.A systemic administration of NMDA induces immediate early gene pip92 in the hippocampus.Modulation of neurotransmission by cannabinoids in the basal ganglia.Novel telomerase-increasing compound in mouse brain delays the onset of amyotrophic lateral sclerosisAttempts of ranking in a series of synthetic nonpsychotropic cannabinoids.Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms.Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs.Psychiatric morbidity in ketamine users attending counselling and youth outreach services.Medial prefrontal cortex N-methyl-D-aspartate receptor/nitric oxide/cyclic guanosine monophosphate pathway modulates both tachycardic and bradycardic baroreflex responses.Synthesis, radio-synthesis and in vitro evaluation of terminally fluorinated derivatives of HU-210 and HU-211 as novel candidate PET tracers.Serial examination of serum IL-8, IL-10 and IL-1Ra levels is significant in neonatal seizures induced by hypoxic-ischaemic encephalopathy.Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB(1) receptors.Polyamines induce blood-brain barrier disruption and edema formation in the rat.Perioperative Management of Severe Traumatic Brain Injury: What Is New?
P2860
Q24198048-2FD5C718-2F2C-4DFF-955B-623A8F2F6D14Q24202656-1997CAD9-AE2C-41D0-AFA9-0C2C5AC70192Q24235307-8BB1C17C-A07F-40D8-B450-EAE31278AB81Q30371428-141F47F0-45D9-425E-9177-E8422D649600Q34096651-58B3BFB7-4EAF-40B5-B6C1-62286DBCE868Q34459205-0226B041-7F07-4AAB-B01D-1DDA2BA0A798Q34490167-92567CFD-A6EE-43DB-99A1-32CF0180C9F4Q34974856-9F3F1574-3169-4631-90EA-419791B965DFQ34974860-3CAF0AB7-18D4-4BDE-AF65-9953363CF686Q35042648-AF1F1569-4B14-485B-9790-DE876EEE70B4Q35171113-959D8203-2D14-4BFE-BA5A-BD311E090307Q35684044-67E51A99-B27B-4A47-9ED5-4B3326AF912CQ35906957-C56C5781-9C0A-4A3F-A0A3-EFAFB4F189B6Q37260316-2E0996B8-AD62-471B-A3DE-0E563864B1F4Q37648343-26C75643-09C0-4671-8E8A-ED8A63AD7E84Q37727119-9ECDEDD4-3A99-4D03-85B2-78EFBAFCE38AQ37960199-37DB8562-C548-457B-9C48-41E6A80C9B01Q38196398-31ABF58C-9C11-4B54-A6DE-16F097374D9CQ38430121-D34415D9-1EAB-49A6-8C7D-3DFF1ED43F93Q38974387-D88E9AA7-B785-498A-B82D-F2826A795EDEQ39000942-A7D1826F-F1A5-4531-B3A5-753868AC0977Q39172074-AAD8C812-734C-4DCE-9A68-F07CB3396345Q40226550-9CEBCA98-CB66-406C-97C3-16C9E519D0B3Q40784670-07957B92-B53F-4E33-89FB-AA49E92EB0D5Q40873850-03125DC4-F80F-4705-A996-95AE673E889FQ41371378-E1FF2067-643D-4B2B-81AB-4CB0E104B24FQ41875894-4C1FB024-6577-433B-9A0D-58AF79153128Q43791056-230E5DB0-48FB-4241-B2FD-AF70EC55AAD3Q43815277-5CA10DE6-34A1-4F39-99F1-FA9FF03F6B4DQ47107982-950711E4-E542-4F08-809A-2FE84644DFD9Q47844005-26910A9B-DA6A-49E6-A2F1-A5617A874698Q47862410-C8D468E9-AED2-4082-BA2C-744AD7C02510Q48225409-D2CEE167-9C59-4E8B-8410-89E2104D6A88Q48547335-21E9FE35-8B0A-41E1-B625-7B79EA90F800Q48743600-B15D4D2C-F669-48E3-BF10-75A23BBE1ED5Q50753767-0F35DAD1-EE82-42C6-A8D0-88ED7385856AQ58782096-94F5A4B0-FA94-4415-93DA-A234ABDE911E
P2860
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@ast
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@en
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@nl
type
label
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@ast
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@en
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@nl
prefLabel
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@ast
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@en
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@nl
P2093
P2860
P921
P356
P1476
Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
@en
P2093
F Bergmann
J J Feigenbaum
M Sokolovsky
S A Richmond
P2860
P304
P356
10.1073/PNAS.86.23.9584
P407
P577
1989-12-01T00:00:00Z